Interview with Kotaro Yoshioka, MD, PhD
Kotaro Yoshioka, MD, PhD Department of Neurology and Neurological Science, Tokyo Medical and Dental University How did you become interested in the field of
2017 Paper of the Year Award Winner: Richard Finkel, MD
Richard Finkel, MD Nemours Children’s Hospital Talk Title: Treatment of Infantile-onset Spinal Muscular Atrophy with Nusinersen: a Phase 2, Open-label, Dose-escalation Study Biography: Richard S. Finkel, MD is Professor of Neurology at the University of Central Florida School of Medicine, and Chief, Division of Neurology ...
2017 Gewirtz Memorial Scholarship Winner: Karyn Schmidt, PhD
Karyn Schmidt, PhDDana-Farber Cancer InstituteTalk Title: Inhibiting the Androgen Receptor Interaction with the Long Non-Coding RNA SLNCR using 2’-FANA-Modified Oligonucleotides Decreases Melanoma Invasion and Proliferation.Biography: Karyn Schmidt received her PhD in Biochemistry from the University of Rochester in 2013, where she studied in the laboratory of J. ...
Interview with Thorleif Møller, PhD
ThorleifMøller, PhD Mirrx Therapeutics A/S CEO & Founder How did you become interested in the field of oligonucleotides? During my PhD studies at the
2017 OTS Young Investigator Award Winner Keith Gagnon, Ph.D.
Keith Gagnon, PhD. Southern Illinois University Talk Title: A ‘Guided’ Tour of an Early Career in RNA and Nucleic Acid Therapeutics Biography: Dr. Keith T. Gagnon earned his Ph.D. from NC State University under the direction of Dr. E. Stuart Maxwell. His thesis investigated the ...
Interview with Sebastien Burel, PhD
Sebastien Burel, PhD Ionis Pharmaceuticals Director Nonclinical Development How did you become interested in the field of oligonucleotides? Mostly by accident.
Interview with Professor J George Dickson
Professor J George Dickson Chair of Molecular Cell Biology, School of Biological Sciences Royal Holloway - University of London, Egham, Surrey, TW20 0EX, UK.
Interview with Catherine McKeen, PhD
Catherine McKeen, PhD Operations Director Link Technologies How did you become interested in the field of oligonucleotides? I have worked in the oligonucleotide sector since 1994. Initially I worked with Tom Brown in
Interview with Jean Gariepy, PhD
Jean Gariepy, Ph.D. Professor Departments of Medical Biophysics and Pharmaceutical Sciences University of Toronto SRI Research Chair in Biomolecular Engineering and Senior Scientist Physical Sciences Sunnybrook Research Institute
Congratulations to the Winner of the 2016 OTS Lifetime Achievement Award!
Dr. Crooke is founder, chairman, and chief executive officer of Ionis Pharmaceuticals (the company formerly known as Isis Pharmaceuticals). During his tenure at Ionis, he has led the scientific development of a new platform for drug discovery, antisense technology, and engineered the creation of ...
